Feb 07, 2018 21:05 pm UTC| Business
Product revenue up 12% compared to September 2017 quarterU.S. product revenue up 27% compared to the September 2017 quarterCash on hand equals $8.6 million at quarter end Conference Call Begins at 4:30pm EST TodaySlide...
Collectors Universe Reports Operating Results for Second Quarter of Fiscal 2018
Feb 07, 2018 21:03 pm UTC| Business
NEWPORT BEACH, Calif., Feb. 07, 2018 -- Collectors Universe, Inc. (NASDAQ:CLCT), a leading provider of value-added authentication and grading services to dealers and collectors of high-value collectibles, today...
iRhythm Technologies to Present at the RBC Global Healthcare Conference
Feb 07, 2018 21:03 pm UTC| Business
SAN FRANCISCO, Feb. 07, 2018 -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today announced the company will be participating in...
Stericycle to Participate in Two Investor Events in March
Feb 07, 2018 21:02 pm UTC| Business
LAKE FOREST, Ill., Feb. 07, 2018 -- Stericycle, Inc. (NASDAQ:SRCL) will give a presentation on Monday, March 5th by Charlie Alutto, President and CEO and Dan Ginnetti, CFO, at 2:15 PM Eastern time at the Raymond James...
pSivida Corp. Reports Second Quarter FY2018 Results; Continues to Achieve Milestones and Timelines
Feb 07, 2018 21:02 pm UTC| Business
Newly Released Second Phase 3 Study Data for Durasert Three-Year Treatment for Posterior Segment Uveitis Shows Positive Efficacy and Safety Profile Maintained at 12 Months Awaiting FDA Decision to Accept NDA...
Inuvo Reports Financial Results for the Fourth Quarter and Full Year Ending December 31, 2017
Feb 07, 2018 21:01 pm UTC| Business
LITTLE ROCK, Ark., Feb. 07, 2018 -- Inuvo, Inc. (NYSE:INUV), an advertising technology company, today reported its financial results for the fourth quarter and full year period ending December 31, 2017. Revenue for the...
Aptose Biosciences Files New Preliminary Base Shelf Prospectus to Replace Expired Base Prospectus
Feb 07, 2018 21:01 pm UTC| Business
SAN DIEGO and TORONTO, Feb. 07, 2018 -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing highly differentiated therapeutics that target the underlying...
South Africa’s plan to move away from coal: 8 steps to make it succeed
Germany lowers voting age to 16 for the European elections
IceCube researchers detect a rare type of energetic neutrino sent from powerful astronomical objects